ENTITY
Ocumension Therapeutics

Ocumension Therapeutics (1477 HK)

30
Analysis
Health CareChina
Ocumension Therapeutics operates as a pharmaceutical company. The Company focuses on identifying, developing, and commercializing ophthalmic therapies. Ocumension Therapeutics serves customers in the United States and China.
more
Refresh
12 Jul 2020 15:57

ECM Weekly (12 July 2020) - Ocumension and Smoore, Simcere, Blue Moon, Weihai City Bank, Radiance

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...

Share
09 Jul 2020 13:29

Ocumension Therapeutics IPO: Trading Debut

Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...

Logo
402 Views
Share
09 Jul 2020 11:07

Ocumension (欧康维视) IPO Trading: Share Could Double Thanks to Record Demand

Ocumension raised HKD 1,424 million (USD 183 m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our previous...

Logo
384 Views
Share
05 Jul 2020 09:36

ECM Weekly (4 July 2020) - Smoore, Ocumension, Zhenro Services, Archosaur Games

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It...

Share
30 Jun 2020 20:49

Ocumension Therapeutics IPO: Valuation Insights

Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...

Logo
657 Views
Share
x